APA (7th ed.) Citation

J, C., L, Z., M, G., & S, M. (2026). Mechanistic drivers of PD-L1/CTLA-4 checkpoint inhibitor-associated immune toxicity and systemic organ injury. Frontiers in oncology, 16, 1808024. https://doi.org/10.3389/fonc.2026.1808024

Chicago Style (17th ed.) Citation

J, Chen, Zhang L, Gao M, and Min S. "Mechanistic Drivers of PD-L1/CTLA-4 Checkpoint Inhibitor-associated Immune Toxicity and Systemic Organ Injury." Frontiers in Oncology 16 (2026): 1808024. https://doi.org/10.3389/fonc.2026.1808024.

MLA (9th ed.) Citation

J, Chen, et al. "Mechanistic Drivers of PD-L1/CTLA-4 Checkpoint Inhibitor-associated Immune Toxicity and Systemic Organ Injury." Frontiers in Oncology, vol. 16, 2026, p. 1808024, https://doi.org/10.3389/fonc.2026.1808024.